Skip to content
10-Q

Quarterly Report

NeuBase Therapeutics, Inc.

0001558370-23-014851

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 11, 2023 2.36M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.69M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.69M sh
Shares Diluted Q2 2023 · Jun 30, 2022 1.61M sh
Shares Diluted Q2 2023 · Jun 30, 2022 1.62M sh
Capex Q2 2023 · Jun 30, 2023 $13.45K
Capex Q2 2023 · Jun 30, 2022 $319.03K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$7.09M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$17.11M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $14.75M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $17.39M
Stockholders Equity Q2 2023 · Jun 30, 2023 $11.25M
Stockholders Equity Q2 2023 · Mar 31, 2023 $14.45M
Stockholders Equity Q2 2023 · Dec 31, 2022 $18.22M
Stockholders Equity Q2 2023 · Jun 30, 2022 $30.31M
Stockholders Equity Q2 2023 · Mar 31, 2022 $38.16M
Stockholders Equity Q2 2023 · Dec 31, 2021 $47.13M
Current Liabilities Q2 2023 · Jun 30, 2023 $6.12M
Current Liabilities Q2 2023 · Dec 31, 2022 $2.15M
Total Liabilities Q2 2023 · Jun 30, 2023 $11.09M
Total Liabilities Q2 2023 · Dec 31, 2022 $7.36M
Current Assets Q2 2023 · Jun 30, 2023 $15.52M
Current Assets Q2 2023 · Dec 31, 2022 $17.97M
Total Assets Q2 2023 · Jun 30, 2023 $22.33M
Total Assets Q2 2023 · Dec 31, 2022 $25.58M
Eps Diluted Q2 2023 · Jun 30, 2023 −$2.04
Eps Diluted Q2 2023 · Jun 30, 2023 −$4.47
Eps Diluted Q2 2023 · Jun 30, 2022 −$5.26
Eps Diluted Q2 2023 · Jun 30, 2022 −$11.34
Eps Basic Q2 2023 · Jun 30, 2023 −$2.04
Eps Basic Q2 2023 · Jun 30, 2023 −$4.47
Eps Basic Q2 2023 · Jun 30, 2022 −$5.26
Eps Basic Q2 2023 · Jun 30, 2022 −$11.34
Sga Expense Q2 2023 · Jun 30, 2023 $2.4M
Sga Expense Q2 2023 · Jun 30, 2023 $5.32M
Sga Expense Q2 2023 · Jun 30, 2022 $3.6M
Sga Expense Q2 2023 · Jun 30, 2022 $6.7M
Rd Expense Q2 2023 · Jun 30, 2023 $1.28M
Rd Expense Q2 2023 · Jun 30, 2023 $2.52M
Rd Expense Q2 2023 · Jun 30, 2022 $4.76M
Rd Expense Q2 2023 · Jun 30, 2022 $11.59M
Net Income Q2 2023 · Jun 30, 2023 −$3.45M
Net Income Q2 2023 · Jun 30, 2023 −$7.54M
Net Income Q2 2023 · Mar 31, 2023 −$4.09M
Net Income Q2 2023 · Jun 30, 2022 −$8.49M
Net Income Q2 2023 · Jun 30, 2022 −$18.42M
Net Income Q2 2023 · Mar 31, 2022 −$9.92M
Operating Income Q2 2023 · Jun 30, 2023 −$3.69M
Operating Income Q2 2023 · Jun 30, 2023 −$7.85M
Operating Income Q2 2023 · Jun 30, 2022 −$8.36M
Operating Income Q2 2023 · Jun 30, 2022 −$18.29M